DRTS logo

DRTS
ALPHA TAU MEDICAL LTD

2,339
Mkt Cap
$891.54M
Volume
467,686.00
52W High
$11.62
52W Low
$2.81
PE Ratio
-15.34
DRTS Fundamentals
Price
$9.99
Prev Close
$10.13
Open
$10.07
50D MA
$8.24
Beta
0.80
Avg. Volume
307,432.50
EPS (Annual)
-$0.529
P/B
13.17
Rev/Employee
$0.00
$335.70
Loading...
Loading...
News
all
press releases
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week
An extract featuring safety and efficacy results from three studies evaluating its key therapy for pancreatic cancer will be unveiled on Thursday.
Stocktwits
News Placeholder
More News
News Placeholder
Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally
Alpha Tau Medical stock surged after interim glioblastoma data showed complete responses in two patients treated with Alpha DaRT.read more...
Benzinga
News Placeholder
DRTS Stock Surges Pre-Market Even As Retail Traders Debate ‘Too Small’ Brain Cancer Trial Data
The biotech company’s experimental treatment for recurrent glioblastoma resulted in complete responses in 2 of the first 3 patients.
Stocktwits
News Placeholder
Nasdaq, S&P 500 Futures Dip As Trump-Iran Tensions Lift Crude Oil Prices: Why MU, MRAM, MLTX, DRTS, ASTS Are In Focus
Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names.
Stocktwits
News Placeholder
DRTS Stock Rises Overnight: Early US Brain Cancer Trial Results Expected Today
Last week, Alpha Tau Medical completed enrollment in its ReStart study for recurring skin cancer.
Stocktwits
News Placeholder
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Still a Buy?
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Here's Why...
MarketBeat
News Placeholder
Alpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year High - Time to Buy?
Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week High - Here's Why...
MarketBeat
News Placeholder
Alpha Tau Medical (NASDAQ:DRTS) Sees Strong Trading Volume - Here's What Happened
Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume Increase - Here's Why...
MarketBeat
News Placeholder
Alpha Tau Medical (NASDAQ:DRTS) Trading Up 13.6% - Here's What Happened
Alpha Tau Medical (NASDAQ:DRTS) Trading 13.6% Higher - Here's What Happened...
MarketBeat
News Placeholder
DRTS Stock Pops Pre-Market: Retail Hype Soars On Cancer Trial Expansion
The company announced key progress in its pancreatic cancer program, including regulatory approval to expand its ongoing trial by enrolling an additional 10 patients.
Stocktwits
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available